To explore the specific mechanisms underlying the protective effects of AXT in COPD, potential targets of AXT in COPD were analyzed using network pharmacology (Fig. 5A). We collected 1106 potential target proteins of COPD and 210 target proteins of AXT from the database. The gene discussed is CNTN2; the disease is chronic obstructive pulmonary disease.